Income Statement
IMAGENEBIO, INC.
IMA
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Revenue
|
0.80 | - | 9.16 | 15.62 | 30.99 |
|
Cost of Revenue
|
- | - | - | - | - |
|
Gross Profit
|
0.80 | - | 9.16 | 15.62 | 30.99 |
|
Operating Expenses
|
49.25 | 58.97 | 84.58 | 86.52 | 65.12 |
|
Research & Development
|
28.53 | 30.88 | 59.65 | 64.32 | 47.11 |
|
Selling, General & Administrative
|
20.73 | 23.68 | 24.93 | 22.20 | 18.02 |
|
Other Operating Expenses
|
- | - | - | - | - |
|
Operating Income
|
-48.45 | -58.97 | -75.42 | -70.90 | -34.14 |
|
Non-Operating Income
|
2.75 | 9.89 | -7.09 | - | - |
|
Interest Income
|
- | - | 7.11 | 2.15 | - |
|
Interest Expense
|
- | - | - | - | - |
|
Other Non-Op Income / Expense
|
0.72 | 2.52 | 7.09 | 2.14 | 0.02 |
|
Income Before Tax
|
-45.70 | -49.08 | -68.33 | - | - |
|
Income Tax Expense
|
-0.35 | 0.15 | -0.16 | - | - |
|
Non-Controlling Interest
|
- | - | - | - | - |
|
Net Income
|
-45.35 | -49.23 | -68.17 | -68.77 | -34.12 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - |
|
EBITDA
|
-48.05 | -58.97 | -75.42 | -70.90 | -34.14 |
|
Earnings Per Share (Basic)
|
-9.64 | -1.02 | -1.63 | -1.90 | - |
|
Diluted EPS
|
-9.64 | -1.02 | -1.63 | -1.90 | - |
|
Weighted Average Shares
|
4.87 | 48.26 | 41.74 | 36.19 | - |
|
Diluted Weighted Avg Shares
|
4.87 | 48.26 | 41.74 | 36.19 | - |
|
Comprehensive Income
|
-45.29 | -49.12 | -67.45 | -69.53 | - |